May 9, 2016 — Results from a first-of-its-kind study identify a significant increase in the incidence of atrial ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
May 9, 2016 — A new study shows the use of novel anticoagulants to treat atrial fibrillation (AF) on an “as needed basis ...
May 9, 2016 — A new study has found an increased risk of dementia in patients with atrial fibrillation (AF) that receive ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 9, 2016 — A new study presented at the Heart Rhythm Society’s 37th Annual Scientific Sessions, found that among ...
May 6, 2016 — Atrial fibrillation patients taking warfarin are at higher risk of developing kidney failure if ...
April 29, 2016 — AtriCure Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the AtriClip PRO2 ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
April 20, 2016 — In the first large randomized trial to directly compare two approaches to preventing atrial ...
David Holmes, M.D., professor of medicine, Mayo Clinic College of Medicine and consultant, Department of Internal ...
April 8, 2016 — New data from an ongoing post-marketing study confirm the safety profile of Xarelto (rivaroxaban) was ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
AliveCor, Inc., the leader in FDA-cleared electrocardiogram (ECG) technology for mobile devices, announced today the ...
March 17, 2016 — Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being ...
March 16, 2016 — The Valley Hospital in Ridgewood, N.J., is one of 15 U.S. sites currently enrolling patients in a ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
March 14, 2016 — Biotronik announced that its BioMonitor 2 heart monitor is now available for patients in the United ...
March 11, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Blazer Open ...
February 18, 2016 — AtriCure Inc. announced that the first patient was enrolled and treated at PinnacleHealth Hospitals ...